). CRISPResso enables accurate quantification and visualization of CRISPR-Cas9 outcomes, as well as comprehensive evaluation of effects on coding sequences, non-coding elements and selected off-target sites. CRISPResso is a suite of computational tools to qualitatively and quantitatively evaluate the outcomes of genome-editing experiments in which target loci are subject to deep sequencing. It provides an integrated, user-friendly interface that can be operated by biologists and bioinformaticians alike ( Supplementary Figs. 1 and 2) . Compared with existing tools 7 , CRISPResso offers several notable features, including the following: batch sample analysis by command line interface; integration with other pipelines; tunable parameters of sequence quality and alignment fidelity; discrete measurement of insertions, deletions and nucleotide substitutions (which are ignored by other methods); tunable windows around the cleavage site to minimize false-positive classification; quantification of frameshift versus in-frame coding mutations; and distinction between NHEJ, HDR and mixed mutation events. CRISPResso automates the following steps: first, filtering low-quality reads; second, trimming adapters; third, aligning the reads to a reference amplicon; fourth, quantifying the proportion of HDR and NHEJ outcomes; and fifth, determining the proportion of frameshift and in-frame mutations as well as detecting potential splice-site mutations. A graphical report is generated to visualize mutagenesis profiles ( Fig. 1 and Supplementary Figs. 3-5) , and plain text output files are also produced for further integrative analyses (Supplementary Note 2). This pipeline can be used for assessment of on-target editing efficacy as well as of off-target editing at selected loci 8, 9 .
We initially assessed the performance and limitations of CRISPResso by performing simulations with various genome-editing outcomes, with and without sequencing errors included (Supplementary Note 3 and Supplementary Figs. 6-9 ). We found that CRISPResso, even in the presence of sequencing errors, robustly and accurately recovered editing events with a negligible false-positive rate (<0.1%). Then we applied CRISPResso to experimental paired-end deep-sequencing data either from cells expressing Cas9 and single guide RNA (sgRNA)-1 targeted to the HBB coding sequence (experiment 1) or from cells expressing Cas9, an extrachromosomal homologous donor template and either sgRNA-2 (experiment 2) or sgRNA-1 (experiment 3), with the intent of targeted introduction of four nucleotide substitutions at HBB (Supplementary Note 4 and Supplementary Figs. 3-5,10) . For experiment 1, CRISPResso provides a quantification of the proportion of NHEJ occurrences, mutated allele size distribution and precise mutation localization with respect to the reference amplicon (Fig. 1a-c) . When coding sequences were provided as an optional input, the software quantified Analyzing CRISPR genome-editing experiments with CRISPResso C O R R E S P O N D E N C E npg VOLUME 34 NUMBER 7 JULY 2016 NATURE BIOTECHNOLOGY frameshift and in-frame mutations and predicted splice site mutations ( Fig. 1d and  Supplementary Fig. 11 ). When an expected HDR amplicon sequence was provided (experiments 2 and 3), CRISPResso was able to deconvolve and characterize unmodified, NHEJ-modified and HDR-modified alleles as distinct outcomes (Fig. 1e,f, Supplementary  Note 1 and Supplementary Figs. 3-5) . In addition, it identified mixed alleles that may result from sequential cleavages initially resulting in HDR and later NHEJ repair (Fig. 1f) . In a case when the donor sequence disrupted the guide RNA seed sequence or the protospacer-adjacent motif (PAM), the relative fraction of mixed events appeared substantially reduced, consistent with the effect of these HDR alleles on resisting subsequent cleavage (Supplementary Figs. 12  and 13) . By specifying the sequence identity required to classify an event as HDR, the user can control the specificity of HDR and the sensitivity of mixed HDR-NHEJ allele detection (Supplementary Figs. 12 and 13) .
In addition, the CRISPResso suite accommodates single-or pooled-amplicon deep sequencing and WGS data sets and allows the direct comparison of individual experiments. In fact, four additional utilities are provided (Supplementary Fig. 1) .
First, CRISPRessoPooled is a tool for the analysis of pooled amplicon experiments that first preprocesses the input data to highlight and remove PCR amplification or trimming artifacts. This tool is recommended to be run in a mixed mode with alignment to both a reference genome and a list of amplicons to help resolve alignment artifacts or contamination (although it may also be run in individual modes). The outputs of CRISPRessoPooled include individual CRISPResso reports with detailed mapping statistics for each region as well as a summary table for all target regions (Supplementary Note 5, Supplementary Figs. 14, 15 and Supplementary Tables 1-6 ). Second, CRISPRessoWGS is a tool for the analysis of WGS data that provides detailed CRISPResso reports for any set of sites throughout the genome (e.g., potential off-target sites) and separate .bam files (for discrete visualization in a genome browser) (Supplementary Note 6 and Supplementary Fig. 16 ). Third, CRISPRessoCompare is a tool for the comparison of two CRISPResso analyses, useful, for example, to compare treated and untreated samples or to compare different experimental conditions (Supplementary Note 7 and Supplementary Fig. 17 ). And finally, CRISPRessoPooledWGSCompare is a tool to compare experiments involving several regions analyzed by either CRISPRessoPooled or CRISPRessoWGS (Supplementary Note 8 and Supplementary Table 7) .
All the analysis presented in this manuscript and the source code of Fig. 11) . (e,f) HDRmediated recombination of an extrachromosomal donor sequence resulting in four substitutions relative to the reference amplicon (experiment 2). (e) When an expected HDR amplicon is provided, CRISPResso classifies sequence reads as HDR if they preferentially align to the expected HDR amplicon sequence and NHEJ (or unmodified) if they preferentially align to the reference amplicon. An alignment threshold may be provided to distinguish HDR alleles from those showing evidence of mixed HDR-NHEJ repair. (f) Mapping of mutation position to reference amplicon of reads classified as NHEJ (left), HDR (center) and mixed HDR-NHEJ (right). In this example with the alignment threshold set to 100% sequence identity, the HDR alleles show only the four expected substitutions, whereas the mixed HDR-NHEJ alleles show additional indels at the predicted cleavage position, consistent with sequential cleavages initially repaired by HDR and subsequently by NHEJ. 57.3% Supplementary  Figs. 1-5 ). This allows analysis of large clinical cohorts and comparison of differential long-term outcomes between treatment regimens. AERSMine facilitates aggregation, subcategorization and simultaneous comparison of multiple patient groups, based on explicit combinations of demographics, clinical indication(s), and exposure to different drug(s) or drug classes. For instance, AERSMine allows users to create mutually exclusive treatment cohorts (e.g., drugs a AND b, OR c, NOT x, y, z) with normalized row values of clinical events (AEs) and generate data matrices for patternbased analyses of differential AE risks and incidence rates (Fig. 1) . These highresolution analyses can enable the detection of differential effects between varied drug classes and within specific, defined patient subgroups that would be otherwise confounded by mixing population subgroups that differ in their relative risks of specific clinical events or outcomes.
C O R R E S P O N D E N C E
Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data
